Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice.

Autor: Yao, Yao, Slosberg, Eric D, Wang, Lei, Hibshoosh, Hanina, Zhang, Yu-Jing, Xing, Wang-Qiu, Santella, Regina M, Weinstein, I Bernard

Publikováno v: Oncogene. 9/16/99, Vol. 18 Issue 37, p5159. 8p.

Phenotypic correction of diabetic mice by adenovirus-mediated glucokinase expression.

Autor: Desai, Urvi J., Slosberg, Eric D., Boettcher, Brian R., Caplan, Shari L., Fanelli, Barbara, Stephan, Zouhair, Gunther, Vicky J., Kaleko, Michael, Connelly, Sheila, Desai, U J, Slosberg, E D, Boettcher, B R, Caplan, S L, Fanelli, B, Stephan, Z, Gunther, V J, Kaleko, M, Connelly, S

Publikováno v: Diabetes; Oct2001, Vol. 50 Issue 10, p2287-2295, 9p, 1 Color Photograph, 2 Diagrams, 5 Charts, 3 Graphs

The protein kinase C β-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells the protein kinase C β-specific inhibitor LY379196 blocks TPA-induced monocytic differentiation of HL60 cells.

Autor: Slosberg, Eric D., Yao, Yao, Xing, Fay, Ikui, Amy, Jirousek, Michael R., Weinstein, I. Bernard

Publikováno v: Molecular Carcinogenesis; Mar2000, Vol. 27 Issue 3, p166-176, 11p

Signature program: a platform of basket trials.

Autor: Slosberg ED; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.; Current affiliation: Daiichi Sankyo, Inc, Basking Ridge, NJ, USA., Kang BP; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Peguero J; Oncology Consultants PA, Houston, TX, USA., Taylor M; Oregon Health and Science University, Portland, OR, USA., Bauer TM; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA., Berry DA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Berry Consultants, Austin, TX, USA., Braiteh F; US Oncology Research and Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA., Spira A; Virginia Cancer Specialists, Fairfax, VA, USA., Meric-Bernstam F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stein S; Incyte, Wilmington, DE, USA., Piha-Paul SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Salvado A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

Publikováno v: Oncotarget [Oncotarget] 2018 Apr 20; Vol. 9 (30), pp. 21383-21395. Date of Electronic Publication: 2018 Apr 20 (Print Publication: 2018).